ACE2 and COVID-19: Moreover, autoantibodies against ACE2 positively correlated with severity of SARS-CoV-2 infection and they were higher in moderate (n = 68) compared to mild (n = 31) COVID-19 patients, and were further increased in severe COVID-19 patients (n = 20) [162].